CAT vs STOK · P/E 48, rev $20.54B vs rev $36.6M
Caterpillar Inc (CAT) versus Stoke Therapeutics Inc (STOK) — a side-by-side from cached financials, not a winner call.
Caterpillar Inc (CAT) is a farm & heavy construction machinery company listed on NYSE. It is led by Jim Umpleby.
Stoke Therapeutics Inc (STOK) is a biotechnology company listed on NASDAQ.
Latest reported CAT revenue for 2026-06-30 was $20.54B. Net income was $3.59B. Revenue was up 18.0% from 2026-03-31 to 2026-06-30. CAT currently screens at market cap $440.29B and trailing P/E 47.7.
Latest reported STOK revenue for 2024-12-31 was $36.6M. Net income was -$89.0M. Revenue was up 316.3% from 2023-12-31 to 2024-12-31. STOK currently screens at market cap $1.88B.
CAT currently screens at market cap $440.29B and trailing P/E 47.7. STOK currently screens at market cap $1.88B.
Not investment advice. Open the CAT and STOK stock pages for the full models.
Not investment advice.